Skip to content
Press

Launching new clinical study

Published on Mar 25, 2026
Launching new clinical study

Building on previous studies, endogene.bio is launching a new clinical study in endometriosis to expand patient cohorts and deepen our understanding of disease biology.

The study will support ongoing efforts to generate the biological data needed to improve diagnosis, patient stratification, and therapeutic development.

About endogene.bio

endogene.bio generates high-resolution biological data from menstrual blood, unlocking a previously inaccessible layer of human uterine biology. Our platform enables disease understanding, patient stratification, and therapeutic discovery across uterine health.